Cholinergic modulation of working memory activity in primate prefrontal cortex

Journal of Neurophysiology

Volumn 106, Issue 5, 2011, Pages 2180-2188

  Zhou, Xin ^a   Qi, Xue Lian ^a   Douglas, Kristy ^a   Palaninathan, Kathini ^a   Kang, Hyun Sug ^b   Buccafusco, Jerry J ^b   Blake, David T ^b   Constantinidis, Christos ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

Monkey; Neuron; Persistent activity; Principal sulcus; Scopolamine

Indexed keywords

ACETYLCHOLINE; MUSCARINIC RECEPTOR; SCOPOLAMINE;

ANIMAL EXPERIMENT; ARTICLE; ATTENTION; BEHAVIOR; BRAIN NERVE CELL; CHOLINERGIC SYSTEM; CONTROLLED STUDY; DOSE RESPONSE; ELECTRODE; EYE MOVEMENT; MACACA MULATTA; MALE; NONHUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; SACCADIC EYE MOVEMENT; TASK PERFORMANCE; VISION; WORKING MEMORY;

ACETYLCHOLINE; ANIMALS; CHOLINERGIC NEURONS; CONDITIONING (PSYCHOLOGY); ELECTRODES, IMPLANTED; ELECTROPHYSIOLOGY; MACACA MULATTA; MALE; MEMORY, SHORT-TERM; MUSCARINIC ANTAGONISTS; PREFRONTAL CORTEX; PSYCHOMOTOR PERFORMANCE; REACTION TIME; SACCADES; SCOPOLAMINE HYDROBROMIDE; SPACE PERCEPTION; SYNAPTIC TRANSMISSION;

EID: 80755188039     PISSN: 00223077     EISSN: 15221598     Source Type: Journal    
DOI: 10.1152/jn.00148.2011     Document Type: Article

References (59)

1. Arnsten AF, Li BM. Neurobiology of executive functions: catecholamine influences on prefrontal cortical functions. Biol Psychiatry 57: 1377-1384, 2005.
2. Bakin JS, Weinberger NM. Induction of a physiological memory in the cerebral cortex by stimulation of the nucleus basalis. Proc Natl Acad Sci USA 93: 11219-11224, 1996.
3. Barraclough DJ, Conroy ML, Lee D. Prefrontal cortex and decision making in a mixed-strategy game. Nat Neurosci 7: 404-410, 2004.
4. Bartus RT, Johnson HR. Short-term memory in the rhesus monkey: disruption from the anti-cholinergic scopolamine. Pharmacol Biochem Behav 5: 39-46, 1976.
5. Bartus RT, Dean RL, 3rd Beer B, Lippa AS. The cholinergic hypothesis of geriatric memory dysfunction. Science 217: 408-414, 1982.
6. Birks JS, Harvey R. Donepezil for dementia due to Alzheimer's disease. Cochrane Database Syst Rev CD001190, 2003.
7. Bolden C, Cusack B, Richelson E. Antagonism by antimuscarinic and neuroleptic compounds at the five cloned human muscarinic cholinergic receptors expressed in Chinese hamster ovary cells. J Pharmacol Exp Ther 260: 576-580, 1992.
8. Buccafusco JJ, Terry AV. Donepezil-induced improvement in delayed matching accuracy by young and old rhesus monkeys. J Mol Neurosci 24: 85-91, 2004.
9. Buccafusco JJ, Terry AV Jr, Webster SJ, Martin D, Hohnadel EJ, Bouchard KA, Warner SE. The scopolamine-reversal paradigm in rats and monkeys: the importance of computer-assisted operant-conditioning memory tasks for screening drug candidates. Psychopharmacology (Berl) 199: 481-494, 2008.
10. Chudasama Y, Dalley JW, Nathwani F, Bouger P, Robbins TW. Cholinergic modulation of visual attention and working memory: dissociable effects of basal forebrain 192-IgG-saporin lesions and intraprefrontal infusions of scopolamine. Learn Mem 11: 78-86, 2004.
11. Constantinidis C, Procyk E. The primate working memory networks. Cogn Affect Behav Neurosci 4: 444-465, 2004.
12. Constantinidis C, Franowicz MN, Goldman-Rakic PS. The sensory nature of mnemonic representation in the primate prefrontal cortex. Nat Neurosci 4: 311-316, 2001.
13. Courtney C, Farrell D, Gray R, Hills R, Lynch L, Sellwood E, Edwards S, Hardyman W, Raftery J, Crome P, Lendon C, Shaw H, Bentham P. Long-term donepezil treatment in 565 patients with Alzheimer's disease (AD2000): randomised double-blind trial. Lancet 363: 2105-2115, 2004.
14. Deutsch JA. The cholinergic synapse and the site of memory. Science 174: 788-794, 1971.
15. Doody RS, Geldmacher DS, Gordon B, Perdomo CA, Pratt RD. Openlabel, multicenter, phase 3 extension study of the safety and efficacy of donepezil in patients with Alzheimer disease. Arch Neurol 58: 427-433, 2001.
16. Drachman DA. Memory and cognitive function in man: does the cholinergic system have a specific role? Neurology 27: 783-790, 1977.
17. Ebert U, Kirch W. Scopolamine model of dementia: electroencephalogram findings and cognitive performance. Eur J Clin Invest 28: 944-949, 1998.
18. Everitt BJ, Robbins TW. Central cholinergic systems and cognition. Annu Rev Psychol 48: 649-684, 1997.
19. Freund HJ, Kuhn J, Lenartz D, Mai JK, Schnell T, Klosterkoetter J, Sturm V. Cognitive functions in a patient with Parkinson-dementia syndrome undergoing deep brain stimulation. Arch Neurol 66: 781-785, 2009.
20. Froemke RC, Merzenich MM, Schreiner CE. A synaptic memory trace for cortical receptive field plasticity. Nature 450: 425-429, 2007.
21. Funahashi S, Bruce CJ, Goldman-Rakic PS. Mnemonic coding of visual space in the monkey's dorsolateral prefrontal cortex. J Neurophysiol 61: 331-349, 1989.
22. Furey ML, Pietrini P, Haxby JV. Cholinergic enhancement and increased selectivity of perceptual processing during working memory. Science 290: 2315-2319, 2000.
23. Fuster JM, Alexander GE. Neuron activity related to short-term memory. Science 173: 652-654, 1971.
24. Goldman-Rakic PS. Cellular basis of working memory. Neuron 14: 477-485, 1995.
25. Harris KD, Henze DA, Csicsvari J, Hirase H, Buzsaki G. Accuracy of tetrode spike separation as determined by simultaneous intracellular and extracellular measurements. J Neurophysiol 84: 401-414, 2000.
26. Heise GA. Behavioral methods for measuring effects of drugs on learning and memory in animals. Med Res Rev 4: 535-558, 1984.
27. Herrero JL, Roberts MJ, Delicato LS, Gieselmann MA, Dayan P, Thiele A. Acetylcholine contributes through muscarinic receptors to attentional modulation in V1. Nature 454: 1110-1114, 2008.
28. Juliano SL, Ma W, Eslin D. Cholinergic depletion prevents expansion of topographic maps in somatosensory cortex. Proc Natl Acad Sci USA 88: 780-784, 1991.
29. Kilgard MP, Merzenich MM. Cortical map reorganization enabled by nucleus basalis activity. Science 279: 1714-1718, 1998.
30. Kim JN, Shadlen MN. Neural correlates of a decision in the dorsolateral prefrontal cortex of the macaque. Nat Neurosci 2: 176-185, 1999.
31. Klinkenberg I, Blokland A. The validity of scopolamine as a pharmacological model for cognitive impairment: a review of animal behavioral studies. Neurosci Biobehav Rev 34: 1307-1350, 2010.
32. Mansouri FA, Buckley MJ, Tanaka K. Mnemonic function of the dorsolateral prefrontal cortex in conflict-induced behavioral adjustment. Science 318: 987-990, 2007.
33. Mesulam M. The cholinergic lesion of Alzheimer's disease: pivotal factor or side show? Learn Mem 11: 43-49, 2004.
34. Metherate R, Cox CL, Ashe JH. Cellular bases of neocortical activation: modulation of neural oscillations by the nucleus basalis and endogenous acetylcholine. J Neurosci 12: 4701-4711, 1992.
35. Metherate R, Tremblay N, Dykes RW. The effects of acetylcholine on response properties of cat somatosensory cortical neurons. J Neurophysiol 59: 1231-1252, 1988.
36. Meyer T, Constantinidis C. A software solution for the control of visual behavioral experimentation. J Neurosci Methods 142: 27-34, 2005.
37. Meyer T, Qi XL, Stanford TR, Constantinidis C. Stimulus selectivity in dorsal and ventral prefrontal cortex after training in working memory tasks. J Neurosci 31: 6266-6276, 2011.
38. Miller EK, Cohen JD. An integrative theory of prefrontal cortex function. Annu Rev Neurosci 24: 167-202, 2001.
39. Miller EK, Desimone R. Scopolamine affects short-term memory but not inferior temporal neurons. Neuroreport 4: 81-84, 1993.
40. Penetar DM, McDonough JH Jr. Effects of cholinergic drugs on delayed match-to-sample performance of rhesus monkeys. Pharmacol Biochem Behav 19: 963-967, 1983.
41. Plakke B, Ng CW, Poremba A. Scopolamine impairs auditory delayed matching-to-sample performance in monkeys. Neurosci Lett 438: 126-130, 2008.
42. Qi XL, Katsuki F, Meyer T, Rawley JB, Zhou X, Douglas KL, Constantinidis C. Comparison of neural activity related to working memory in primate dorsolateral prefrontal and posterior parietal cortex. Front Syst Neurosci 4: 12, 2010.
43. Qi XL, Meyer T, Stanford TR, Constantinidis C. Changes in prefrontal neuronal activity after learning to perform a spatial working memory task. Cereb Cortex. In press.
44. Renner UD, Oertel R, Kirch W. Pharmacokinetics and pharmacodynamics in clinical use of scopolamine. Ther Drug Monit 27: 655-665, 2005.
45. Richardson RT, DeLong MR. Context-dependent responses of primate nucleus basalis neurons in a go/no-go task. J Neurosci 10: 2528-2540, 1990.
46. Richardson RT, DeLong MR. Electrophysiological studies of the functions of the nucleus basalis in primates. Adv Exp Med Biol 295: 233-252, 1991.
47. Richardson RT, DeLong MR. Nucleus basalis of Meynert neuronal activity during a delayed response task in monkey. Brain Res 399: 364-368, 1986.
48. Robbins TW, Arnsten AF. The neuropsychopharmacology of fronto-executive function: monoaminergic modulation. Annu Rev Neurosci 32: 267-287, 2009.
49. Rogers SL, Farlow MR, Doody RS, Mohs R, Friedhoff LT. A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease. Donepezil Study Group. Neurology 50: 136-145, 1998.
50. Rolls ET, Loh M, Deco G, Winterer G. Computational models of schizophrenia and dopamine modulation in the prefrontal cortex. Nat Rev Neurosci 9: 696-709, 2008.
51. Sarter M, Parikh V. Choline transporters, cholinergic transmission and cognition. Nat Rev Neurosci 6: 48-56, 2005.
52. Spingath EY, Kang HS, Plummer T, Blake DT. Different neuroplasticity for task targets and distractors. PLoS One 6: e15342, 2011.
53. Steriade M, Amzica F. Intracortical and corticothalamic coherency of fast spontaneous oscillations. Proc Natl Acad Sci USA 93: 2533-2538, 1996.
54. Taffe MA, Weed MR, Gold LH. Scopolamine alters rhesus monkey performance on a novel neuropsychological test battery. Brain Res Cogn Brain Res 8: 203-212, 1999.
55. Terry AV Jr, Buccafusco JJ. The cholinergic hypothesis of age and Alzheimer's disease-related cognitive deficits: recent challenges and their implications for novel drug development. J Pharmacol Exp Ther 306: 821-827, 2003.
56. Wallis JD, Anderson KC, Miller EK. Single neurons in prefrontal cortex encode abstract rules. Nature 411: 953-956, 2001.
57. Webster HH, Hanisch UK, Dykes RW, Biesold D. Basal forebrain lesions with or without reserpine injection inhibit cortical reorganization in rat hindpaw primary somatosensory cortex following sciatic nerve section. Somatosens Mot Res 8: 327-346, 1991.
58. Winblad B, Engedal K, Soininen H, Verhey F, Waldemar G, Wimo A, Wetterholm AL, Zhang R, Haglund A, Subbiah P. A 1-year, randomized, placebo-controlled study of donepezil in patients with mild to moderate AD. Neurology 57: 489-495, 2001.
59. 11C](+)3-MPB and scopolamine in conscious monkeys. Neuropsychopharmacology 36: 1455-1465, 2011.